Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by Neostigmine
NCT05224648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2023-01-13
Summary
Despite neuromuscular transmission monitoring and pharmacological reversal allowing a train of four ratio recovery higher than 0.9, patients receiving neuromuscular blocking agent during general anesthesia have a high risk of postoperative pulmonary complications. While this train of four ratio threshold is considered as the gold standard to confirm the lack of residual paralysis, tetanus 100 Hz stimulation showed a marked fade. This result has been observed in absence of reversal agent administration.
Therefore, the present study has been designed to compare the recovery of train of four stimulation, tetanus 50 Hz and tetanus 100 Hz stimulation in patient receiving rocuronium during general anesthesia and reversed by an anticholinesterase agent (neostigmine). Neostigmine will be injected once four muscular contractions of the adductor pollicis muscle will be observed after a train of four stimulation, at a dose (40 µg/kg) in accordance with the clinical practice worldwide admitted.
Two questions have to be investigated. First, is this dose of neostigmine sufficient to allow a complete recovery of tetanus stimulations ? Second, due to the pharmacological properties of neostigmine, does a recurarisation phenomenon occur following repeated tetanus stimulations ? The attented results of this study will be to propose a new thinking on what we really need to make relevant progress in the safety aspects of residual paralysis outcome.
Conditions
- Postoperative Residual Curarization
Interventions
- DEVICE
-
TOF scan train of four ratio monitoring
Device : TOF Scan For each included patient, 2 monitorings (TOF Scan and ITF device) will be placed, one on each hand. Once 4 contractions of the adductor pollicis muscle will be observed on the TOF Scan side following train of four stimulation, 40 µg/kg neostigmine will be injected. Train of four ratio (delivered every minute) will be recorded. This sequence (tetanus 100 Hz followed by tetanus 50 Hz) will be repeated 6 times. For each tetanus stimulation, the ratio between the residual force and the maximum force generated by the adductor pollicis muscle will be recorded (this ratio illustrates the fade phenomenon). At the end of this period lasting 30 minutes after neostigmine administration, anesthetic drug delivery will be stopped and the patient wil be allowed to recover.
- DEVICE
-
ITF device tetanus stimulation monitoring
Device ITF For each included patient, 2 monitorings (TOF Scan and ITF device) will be placed, one on each hand. Once 4 contractions of the adductor pollicis muscle will be observed on the TOF Scan side following train of four stimulation, 40 µg/kg neostigmine will be injected. Train of four ratio (delivered every minute) will be recorded. This sequence (tetanus 100 Hz followed by tetanus 50 Hz) will be repeated 6 times. For each tetanus stimulation, the ratio between the residual force and the maximum force generated by the adductor pollicis muscle will be recorded (this ratio illustrates the fade phenomenon). At the end of this period lasting 30 minutes after neostigmine administration, anesthetic drug delivery will be stopped and the patient wil be allowed to recover.
Sponsors & Collaborators
-
Poitiers University Hospital
lead OTHER
Principal Investigators
-
Bertrand Debaene, MD phD · CHU de Poitiers FRANCE
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-22
- Primary Completion
- 2022-11-17
- Completion
- 2022-11-18
Countries
- France
Study Locations
More Related Trials
-
Awakening in Spine Surgery: A Comparison Between Clinical Signs and Bispectral Index
NCT02174913 ·Status: COMPLETED ·Phase: NA
-
Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine
NCT06029049 ·Status: RECRUITING ·Phase: PHASE4
-
Dual-loop Target Controlled Infusion for Coadministration of Propofol and Remifentanil Guided by Narcotrend Index
NCT02890186 ·Status: UNKNOWN ·Phase: PHASE4
-
A Comparison of Rocuronium 0.3 mg/kg, and 0.9 mg/kg for Induction of Anesthesia in Elderly Patients.
NCT04512313 ·Status: COMPLETED ·Phase: NA
-
Reduction of Remifentanil-related Complications
NCT01003028 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Effect of Palonosetron on the QTc Interval During Perioperative Period
NCT01650961 ·Status: COMPLETED ·Phase: NA
-
Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness
NCT07274683 ·Status: NOT_YET_RECRUITING
-
Pharmacokinetics and Pharmacodynamics of Rocuronium in Closed-Loop Infusion System
NCT02364934 ·Status: UNKNOWN
-
Interest of the Study of Electroencephalogram and Peripheral Vegetative Markers for the Evaluation of Nociception Under General Anesthesia.
NCT03994887 ·Status: WITHDRAWN ·Phase: NA
-
Interindividual Variability in Duration of Action of Rocuronium in Pediatric Patients
NCT05529420 ·Status: COMPLETED
-
The Effect of Bilateral Infraorbital and Infratrochlear Nerve Block on Perioperative Period of Hypophysectomy
NCT05555147 ·Status: UNKNOWN ·Phase: NA
-
Effect of Remifentanil on Pruritus and Paresthesia of Fospropofol Disodium Anesthesia
NCT07092384 ·Status: COMPLETED ·Phase: NA
-
Comparison of Neuromuscular Blockade's Monitoring and Clinical Assessment During Cisatracurium Paralysis in Critically Ill Patients
NCT03198637 ·Status: COMPLETED ·Phase: PHASE3
-
Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane
NCT02711917 ·Status: COMPLETED ·Phase: NA
-
Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor
NCT02813044 ·Status: COMPLETED ·Phase: NA
-
Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients
NCT07064408 ·Status: COMPLETED ·Phase: NA
-
The Effect Site Concentration of Remifentanil for Conscious Sedation During Awake Nasotracheal Fiberoptic Intubation
NCT01052324 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Depth of Anesthesia on Pupillary Reactivity to a Standardized Stimulus
NCT02595476 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Fentanyl Consumption Guided by Analgesia Nociception Index
NCT03716453 ·Status: COMPLETED ·Phase: NA
-
The Effects of Spinal Anesthesia on ED50 and BIS50 of Etomidate for the Loss of Consciousness
NCT03240055 ·Status: COMPLETED ·Phase: NA
-
Effects of Intravenous Anesthesia and Balanced Anesthesia on Flash Visual Evoked Potentials
NCT04725032 ·Status: RECRUITING ·Phase: NA
-
Anaesthetic and Pediatric Living Related Liver Transplantation
NCT03024840 ·Status: UNKNOWN ·Phase: NA
-
Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults
NCT03065309 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy
NCT01703351 ·Status: COMPLETED ·Phase: PHASE2
-
Intubation Time With Low Dose Rocuronium
NCT01464489 ·Status: COMPLETED ·Phase: NA